Please login to the form below

Not currently logged in
Email:
Password:

biopharma

This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

AbbVie offered $55bn for the biopharma in 2014, but the transaction was abandoned after the US introduced new measures to discourage tax inversion deals.

Latest news

More from news
Approximately 8 fully matching, plus 400 partially matching documents found.

Latest Intelligence

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma.

  • Communication is the key to the participatory medicine model Communication is the key to the participatory medicine model

    Healthcare systems are in need of external support to speed-up best practice adoption, with biopharma ideally placed to assist. ... Biopharma can play a key role in providing training for physicians that coaches them on optimal patient communication

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    Naomi O’Connell, Shire’s head of advertising and promotion, global operations, admits that the digitisation process needs to improve throughout the biopharma industry.

  • Significant figures Significant figures

    It all seems a long way from 2014’s disappointing news for the biopharma when ALIS failed to meet its primary endpoint in a phase II trial.

More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest appointments

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Rare genetic disease focused biopharma Abeona Therapeutics has named its chief executive officer in the form of Carsten Thiel. ... Following a 25-year career in the biopharmaceutical industry, Thiel has held numerous roles for several biopharma’s

  • Dermavant strengthens executive team Dermavant strengthens executive team

    Alongside Rubenstein, Richard Peterson joins the biopharma as its chief financial officer. ... Jasie has joined the biopharma from Codiak BioSciences, where he served as chief business officer and prior to that, he served in various executive roles at

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    Ipsen bolsters leadership team. Ivana Magovcevic-Liebisch and Régis Mulot join the biopharma. ... With over 20 years of senior management service experience in biopharma, Magovcevic-Liebisch joins Ipsen from Axcella Health, where she served as executive

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer Schranz. ... Dr Schranz joins Nabriva from Irish biopharma Shire, with nearly two decades of experience in

  • Hansa Medical poaches Vifor Pharma’s CEO Hansa Medical poaches Vifor Pharma’s CEO

    Hansa Medical poaches Vifor Pharma’ s CEO. Søren Tulstrup becomes the Swedish biopharma’s CEO and president. ... Ulf Wiinberg, chairman at Hansa Medical, said: “Søren is an accomplished life science industry executive, who brings diverse and

More from appointments
Approximately 8 fully matching, plus 127 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics